Clinical trials
Phase 3 Renal Insufficiency, Chronic trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kyunghee University Medical Center | 2 |
| Ain Shams University | 1 |
| Corbridge Group Philippines, Inc. | 1 |
| Espero Biopharma | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| Fundación de Ayuda a la Investigación sobre la Hipertensión, Riesgo Cardiovascular y Enfermedades Renales | 1 |
| Heleen Grootjans | 1 |
| Imam Khomeini Hospital | 1 |
| Instituto Nacional de Cardiologia Ignacio Chavez | 1 |
| Laboratório Químico Farmacêutico Bergamo Ltda. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renal Insufficiency, Chronic | 21 |
| Kidney Failure, Chronic | 5 |
| Anemia | 2 |
| Diabetes Mellitus | 2 |
| Kidney Diseases | 2 |
| Acute Kidney Injury | 1 |
| Cardiovascular Diseases | 1 |
| Disease Progression | 1 |
| Hepatitis B | 1 |
| Hyperphosphatemia | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.